156 related articles for article (PubMed ID: 16826430)
1. Bosentan inhibits tumor vascularization and bone metastasis in an immunocompetent skin-fold chamber model of breast carcinoma cell metastasis.
Dréau D; Karaa A; Culberson C; Wyan H; McKillop IH; Clemens MG
Clin Exp Metastasis; 2006; 23(1):41-53. PubMed ID: 16826430
[TBL] [Abstract][Full Text] [Related]
2. The endothelin axis stimulates the expression of pro-inflammatory cytokines and pro-migratory molecules in breast cancer.
Jewell AN; Swamydas M; Castillo CI; Wyan H; Allen LD; McDermott KA; Eddy JM; Dréau D
Cancer Invest; 2010 Nov; 28(9):932-43. PubMed ID: 20690805
[TBL] [Abstract][Full Text] [Related]
3. Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2.
Lau WM; Weber KL; Doucet M; Chou YT; Brady K; Kowalski J; Tsai HL; Yang J; Kominsky SL
Int J Cancer; 2010 Feb; 126(4):876-84. PubMed ID: 19642106
[TBL] [Abstract][Full Text] [Related]
4. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
[TBL] [Abstract][Full Text] [Related]
5. Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis.
Siclari VA; Mohammad KS; Tompkins DR; Davis H; McKenna CR; Peng X; Wessner LL; Niewolna M; Guise TA; Suvannasankha A; Chirgwin JM
Breast Cancer Res; 2014 Dec; 16(6):458. PubMed ID: 25439669
[TBL] [Abstract][Full Text] [Related]
6. Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis.
Bachelier R; Confavreux CB; Peyruchaud O; Croset M; Goehrig D; van der Pluijm G; Clézardin P
Int J Cancer; 2014 Sep; 135(6):1319-29. PubMed ID: 24615579
[TBL] [Abstract][Full Text] [Related]
7. Surgically-Induced Multi-organ Metastasis in an Orthotopic Syngeneic Imageable Model of 4T1 Murine Breast Cancer.
Zhang Y; Zhang N; Hoffman RM; Zhao M
Anticancer Res; 2015 Sep; 35(9):4641-6. PubMed ID: 26254353
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
Hardee ME; Cao Y; Fu P; Jiang X; Zhao Y; Rabbani ZN; Vujaskovic Z; Dewhirst MW; Arcasoy MO
PLoS One; 2007 Jun; 2(6):e549. PubMed ID: 17579721
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of osteoblastic metastases: role of endothelin-1.
Mohammad KS; Guise TA
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S67-74. PubMed ID: 14600594
[TBL] [Abstract][Full Text] [Related]
10. Effect of a V-ATPase inhibitor, FR202126, in syngeneic mouse model of experimental bone metastasis.
Niikura K
Cancer Chemother Pharmacol; 2007 Sep; 60(4):555-62. PubMed ID: 17187252
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
[TBL] [Abstract][Full Text] [Related]
13. A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis.
Yi M; Ruoslahti E
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):620-4. PubMed ID: 11209058
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
15. Panax notoginseng saponins (PNS) inhibits breast cancer metastasis.
Wang P; Cui J; Du X; Yang Q; Jia C; Xiong M; Yu X; Li L; Wang W; Chen Y; Zhang T
J Ethnopharmacol; 2014 Jul; 154(3):663-71. PubMed ID: 24793216
[TBL] [Abstract][Full Text] [Related]
16. Role of endothelin-1 in osteoblastic bone metastases.
Guise TA; Yin JJ; Mohammad KS
Cancer; 2003 Feb; 97(3 Suppl):779-84. PubMed ID: 12548575
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGFβ receptor I kinase.
Buijs JT; Matula KM; Cheung H; Kruithof-de Julio M; van der Mark MH; Snoeks TJ; Cohen R; Corver WE; Mohammad KS; Jonkers J; Guise TA; van der Pluijm G
J Pathol; 2015 Apr; 235(5):745-59. PubMed ID: 25421310
[TBL] [Abstract][Full Text] [Related]
18. STC1 expression is associated with tumor growth and metastasis in breast cancer.
Chang AC; Doherty J; Huschtscha LI; Redvers R; Restall C; Reddel RR; Anderson RL
Clin Exp Metastasis; 2015 Jan; 32(1):15-27. PubMed ID: 25391215
[TBL] [Abstract][Full Text] [Related]
19. Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone.
Zwolak P; Jasinski P; Terai K; Gallus NJ; Ericson ME; Clohisy DR; Dudek AZ
Eur J Cancer; 2008 Nov; 44(16):2506-17. PubMed ID: 18723339
[TBL] [Abstract][Full Text] [Related]
20. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR
Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
